In this article we will be reporting about hedge fund’s favorite heathcare stocks. Insider Monkey, your source for free insider trading data, follows hedge fund managers because they’re the smartest investors around. They leave less to chance than most investors. They go to great lengths to get an “edge” over ordinary investors. Hedge fund managers also have the resources to do extensive research on public companies and they have access to experts who can guide them. We believe we are more likely to beat the market by imitating insiders and hedge funds than trading against them.
Based on the transactions of nearly 700 hedge funds, we compiled the list of the top 9 healthcare stocks hedge funds are crazy about during the most recent fourth quarter:
Pfizer (PFE): Nearly 150 hedge funds own 3% of the outstanding shares of Pfizer. Hedge fund stars like Lee Ainslie, David Einhorn, David Tepper, and Curtis Schenker all own PFE in their portfolio. Bridger’s Roberto Mignone sold all his Pfizer holdings during the fourth quarter. Pfizer was one of the best stock picks in the pharma space. Its peers such as Glaxo Smith (GSK), Novartis (NVS) and Merck (MRK) lost value during the past three months, but Pfizer returned nearly 15% since the middle of December.